Back to company

AMPLEXA GENETICS A/S: Financial statements 2019

CVR: 29428441

AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,830,722 and a net result of DKK -1,500,826 compared with DKK -3,661,357 the year before. That is an increase of 212.1% compared with the year before. Equity amounted to DKK -30,409,686. The company had 7 employees in the financial year.

Gross Profit
2,830,722 kr.
Profit/Loss
-1,500,826 kr.
Equity
-30,409,686 kr.
Total Assets
3,952,009 kr.
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-2.8 mio.-1.5 mio.-30.4 mio.7
2018-907 t.-3.7 mio.-28.9 mio.7
2017-718 t.-3 mio.-25.2 mio.6
2016-440 t.-2.7 mio.-22.3 mio.-
2015-157 t.-3.4 mio.-19.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

AMPLEXA GENETICS A/S: The 2018 annual report is outMay 29, 2019

AMPLEXA GENETICS A/S has published its annual report for 2018. Gross profit came to DKK 906,955, and the net result was DKK -3,661,357.

About AMPLEXA GENETICS A/S

AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.